In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...